Abstract
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
Philip J Mease, Alan J Kivitz, Francis X Burch, Evan L Siegel, Stanley B Cohen, Peter Ory, David Salonen, Joel Rubenstein, John T Sharp, Meleana Dunn and Wayne Tsuji
The Journal of Rheumatology April 2006, 33 (4) 712-721;
Philip J Mease
Alan J Kivitz
Francis X Burch
Evan L Siegel
Stanley B Cohen
Peter Ory
David Salonen
Joel Rubenstein
John T Sharp
Meleana Dunn
In this issue
The Journal of Rheumatology
Vol. 33, Issue 4
1 Apr 2006
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
Philip J Mease, Alan J Kivitz, Francis X Burch, Evan L Siegel, Stanley B Cohen, Peter Ory, David Salonen, Joel Rubenstein, John T Sharp, Meleana Dunn, Wayne Tsuji
The Journal of Rheumatology Apr 2006, 33 (4) 712-721;
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
Philip J Mease, Alan J Kivitz, Francis X Burch, Evan L Siegel, Stanley B Cohen, Peter Ory, David Salonen, Joel Rubenstein, John T Sharp, Meleana Dunn, Wayne Tsuji
The Journal of Rheumatology Apr 2006, 33 (4) 712-721;